IDA Foundation, on behalf of the Stop TB Partnership/The Global Drug Facility (GDF), is today launching an Invitation to Bid (ITB) for the supply of Ethambutol 100mg dispersible tablets for the treatment of drug-sensitive forms of tuberculosis.
With most organisations working from home for over a year now, many of us at IDA will say that we have managed to keep our organisation running quite smoothly. But a big aspect of working life are our colleagues and the office culture. So how are we staying connected to our colleagues and holding on to the IDA team spirit?
On World Health Day, we celebrate the founding of the World Health Organisation (WHO) on April 7 in 1948. This year’s campaign is ‘building a fairer, healthier world’, emphasising the importance of equality in access to healthcare.
Access to good quality healthcare is a challenge for many people in Sudan - a country with a population of almost 43 million people. In the last quarter of 2020 and the first quarter of 2021, IDA assembled over 600 Rapid Response Kits (RRKs) for one of our main customers, to specifically support primary healthcare needs in eight different remote locations in Sudan.
One year into the global COVID-19 pandemic, much of the global focus is currently going to vaccination rollouts, but treatment options are still limited. However, dexamethasone, an essential medicine which has been around for decades (listed by WHO since 1977) – is one of the few approved treatments for severe and critically ill COVID-19 patients.
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
IDA Foundation has published its annual Product Indicator. This booklet provides an overview of the products we supply. The sections on diagnostics and medical supplies are also available in French in addition to English. All medicines and supplies in the Product Indicator are grouped according to the WHO classification of Essential Medicines as listed in the Essential Medicines List (EML).
In 2020, we were all challenged by the COVID-19 pandemic. But the crisis also provided an opportunity to reflect on what's important, whether we are in a crisis or not. More than ever, it has become clear that solid health systems are indispensable when fighting both pandemics and endemics. If we want to overcome any global health crises, we all need to work together.
World AIDS Day, held on December 1 since 1988, is an international day dedicated to creating awareness of the HIV/AIDS burden worldwide. Thus far, of the approximately 38 million people with HIV worldwide, around 26 million are on retroviral therapy, which is triple the number in 2010 (UN Report, 2020). Furthermore, AIDS-related deaths have fallen by 56% since 2005 (UNAIDS, 2019). Despite these achievements, significant challenges remain, with increasing rates of infections in key communities.
Today marks the beginning of World Antimicrobial Awareness Week. This week aims to create awareness around the accelerated threat of antimicrobial resistance (AMR). AMR occurs when bacteria, viruses, fungi and parasites change over time and stop responding to medicines, increasing the risk of diseases and severe illnesses.
Since the early start of the pandemic we have been supplying PPE and other urgent supplies to countries worldwide, and we have seen the effects of the unforeseen costs that come with it. Budgets need to be reassessed and customers must find a balance between products required and increased transport costs.
IDA Foundation, on behalf of the Stop TB Partnership/The Global Drug Facility (GDF), is today launching an Invitation to Bid (ITB) for the supply of ANTI-TUBERCULOSIS MEDICINES AND RELATED PRODUCTS for the treatment of DRUG-RESISTANT FORMS of tuberculosis to eligible manufacturers.
As part of IDA Foundation’s sustainability journey, our headquarters in Amsterdam were renovated in 2018 according to the highest green standards. As the area around our office is currently undergoing many changes, requiring our parking lot to be moved, IDA is taking the opportunity to also turn our office terrain into a climate-adaptive green zone that will benefit the local environment.
On Monday July 6, Johnson & Johnson announced a price reduction of the anti-tuberculosis medicine bedaquiline, for low- and middle-income countries. Thanks to the support of USAID and the Global Fund, this price reduction could be achieved. The price dropped from $400 to $340 for a six-month treatment regimen.
After months of working from home due to the major impact of the COVID-19 pandemic, we can say our staff does not take this as an excuse to stop exercising. The past few weeks our employees were challenged to share their ways of staying fit during this global crisis, with the very first IDA Fit Challenge. We asked colleagues to share how they are staying fit during lockdown.
The global supply chain is heavily impacted by the pandemic spread of the corona virus. Transport options are scarce due to export restrictions and due to countries being in lockdown to prevent the corona virus from further spreading. These regulations pose challenges for us as a supplier of medical goods.
As the Corona virus pandemic spreads around the globe, and all health care systems and governments seem to be engulfed with battling COVID-19, we realise it is more important than ever that we don’t lose sight of other existing health issues.
While coronavirus (COVID-19) dominates the news, we need to remember that another respiratory disease kills 1.5 million people per year: tuberculosis (TB). This is an opportunity to unite forces in the fight against TB and coronavirus.
With corona virus (COVID-19) spreading globally, IDA Foundation is closely monitoring the developments to ensure we are able to respond to any changes. This past week, we were glad to support the Asian Infrastructure Investment Bank (AIIB) by supplying medical goods to be used in the corona virus response in China.
As procurement agent for Stop TB /GDF, we are glad to share this news update as announced by the Stop TB partnership during the 50th Union Conference for Lung Health in Hyderabad, India.
This week (20-27 September) is Global Climate Strike week; also an opportunity for IDA Foundation to step up to support young climate strikers all over the world. Following earlier climate strikes these past years, this week has broken records with millions of people on the streets to take action for our climate. Today, our employees joined the climate strike by ‘striking’ outside our Amsterdam office.
World AIDS Day, held on 1 December every year since 1988, is an international day dedicated to creating awareness of the AIDS pandemic caused by the spread of HIV infection.
We are proud to share positive results from our partner, the USAID Global Health Supply Chain Program-Procurement and Supply Management project this week.
IDA Foundation attended the Portage Inaugural Meeting in Centro Sharjah, UAE. The meeting aims to discuss ways to simplify treatment and access for Children with Cancer in low and middle income countries.
On behalf of Stop TB Partnership’s Global Drug Facility (GDF), IDA Foundation (IDA), the GDF-contracted procurement agent, invites all eligible suppliers to submit bids (ITB) for 1st and 2nd line TB.
As we near the end of September, we look back at Childhood Cancer Awareness Month.